Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis

Peritoneal Dialysis International

Volumn 19, Issue 6, 1999, Pages 517-525

  Mateijsen, Maartje A M ^a   Van Der Wal, Allard C ^b   Hendriks, Pascale M E M ^b   Zweers, Machteld M ^b   Mulder, Jos ^b   Struijk, Dirk G ^b   Krediet, Raymond T ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Morphological changes; Peritoneal sclerosis

Indexed keywords

ALPHA ACTIN; BLOOD CLOTTING FACTOR 8; COLLAGEN TYPE 4; DIALYSIS FLUID; GLUCOSE;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD VESSEL WALL; CAPILLARY; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE DURATION; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PERITONEAL DISEASE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SCLEROSIS; THICKNESS; VASCULAR DISEASE; VASODILATATION;

EID: 0033371503     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900605     Document Type: Article

References (43)

1. Hendriks PMEM, Ho-dac-Pannekeet MM, van Gullik TM, Struijk DG, Phoa SSKS, Sie LH, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients. Analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
2. Oulès R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988; 3:66-9.
3. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
4. Krediet RT, Struijk DG, Boeschoten EW, Koomen GCM, Stouthard JML, Hoek FJ, et al. The time course of peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13:299-307.
5. Dobbie JW. Ultrastructure and pathology of the peritoneum in peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers, 1994:17-44.
6. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
7. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994; 14(Suppl 3):S16-20.
8. Dobbie JW. Morpho-functional correlations in human mesothelium. In: La Greca G, Ronco C, Feriani M, Chiaramonte S, Conz P, eds. Peritoneal dialysis. Milan: Wichtig Editore 1991:33-43.
9. Dobbie JW, Lloyd KW, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma, and blood vessels in uremia and CAPD patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:3-12.
10. Dobbie JW. New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15:97-109.
11. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44:204-11.
12. Di Paolo N, Sacchi G, Capotondo L. Structural changes in peritoneal vessels during continuous ambulatory peritoneal dialysis; a model for the study of diabetic microangiopathy. In: Avram MM, Giordano C, eds. Ambulatory peritoneal dialysis. New York: Plenum, 1990:103-9.
13. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory dialysis (CAPD): an in vivo model for the study of microangiopathy. Perit Dial Int 1989; 9:41-5.
14. Gotloib L, Bar-Sella P, Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: ultrastructural changes of reduplicated peritoneal basement membrane. Perit Dial Bull 1985; 5:212-15.
15. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72:171-6.
16. Coggi G, Dell'Orto P, Viale G. Avidin-biotin methods. In: Polak JM, van Noorden S, eds. Immunocytochemistry. Modern methods and applications. 2nd ed. Bristol: John Wright and Son, 1986:54-70.
17. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11:498-506.
18. Selgas R, Fernandez-Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23:64-73.
19. Struijk DG, Krediet RT, Koomen GCM, Hoek FJ, Boeschoten EW, vd Reijden HJ, et al. Functional characteristics of the peritoneal membrane in long-term continuous peritoneal dialysis. Nephron 1991; 59:213-20.
20. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45:1739-44.
21. Krediet RT, Imholz ALT, Struijk DG, Koomen GCM, Arisz L. Ultrafiltration failure in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2):S59-66.
22. Verger C, Celicout B. Peritoneal permeability and encapsulating peritonitis. Lancet 1985; 1:986-7.
23. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-39.
24. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-7.
25. Tanaka Y, Katoh S, Hori S, Miura M, Yamashita H. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997; 349:1520.
26. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT. The growth factors VEFG and TGFβ-1 in peritoneal dialysis. J Lab Clin Med 1999; 134:124-32.
27. Kollros P, Konkle BA. Microvascular disease in diabetes mellitus. Coron Artery Dis 1996; 7:702-7.
28. Karttunen T, Risteli J, Autio-Harmainen H, Risteli L. Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 1986; 30:586-91.
29. Nakanishi K, Yoshikawa N, Lijima K, Kitagawa K. Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994; 46:1413-21.
30. Ziyadeh FN. Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 1993; 43:114-20.
31. Timpl R. Recent advances in the biochemistry of glomerular basement membrane. Kidney Int 1986; 30:293-8.
32. Danne T, Spiro MJ, Spiro RG. Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes 1993; 42:170-7.
33. Woodrow D, Moss J, Shore I, Spiro RG. Diabetic glomerulosclerosis-immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulphate proteoglycan. J Pathol 1992; 167:49-58.
34. Phillips AO, Steadman R, Morrisey K, Martin J, Eynstone L, Williams JD. Exposure of renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 1997; 52:973-84.
35. Gabbiani G. The biology of the myofibroblasts. Kidney Int 1992; 41:530-2.
36. Pedagogos E, Hewitson T, Fraser I, Nicholls K, Becker G. Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 1997; 29: 912-18.
37. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, El Nahas AM. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997; 12:43-50.
38. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
39. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41:1280-5.
40. Topley N, Coles GA, Williams JD. Bioincompatibility studies on peritoneal cells. Perit Dial Int 1994; 14(Suppl 3):S21-8.
41. Gotloib L, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysate solutions. Nephron 1995; 70:466-77.
42. Pedersen FB, Ryttor N, Deleuran P, Dragsholt C, Kildeberg P. Acetate versus lactate in peritoneal dialysis solutions. Nephron 1985; 39:55-8.
43. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.